Mycobacterial lipoarabinomannan and related lipoglycans: from biogenesis to modulation of the immune responseVolker Briken, Laurent Kremer, Steven A. Porcelli et al.|Molecular Microbiology|2004Cited by 426
The Methyl-Branched Fortifications of Mycobacterium tuberculosisDavid E. Minnikin, Gurdyal S. Besra, Laurent Kremer et al.|Chemistry & Biology|2002Cited by 262
Thiolactomycin and Related Analogues as Novel Anti-mycobacterial Agents Targeting KasA and KasB Condensing Enzymes inMycobacterium tuberculosisLaurent Kremer, Gurdyal S. Besra, James Douglas et al.|Journal of Biological Chemistry|2000Cited by 250
The <i>Mycobacterium tuberculosis</i> FAS‐II condensing enzymes: their role in mycolic acid biosynthesis, acid‐fastness, pathogenesis and in future drug developmentApoorva Bhatt, Laurent Kremer, Virginie Molle et al.|Molecular Microbiology|2007Cited by 227
Overexpression of <i>inhA</i>, but not <i>kasA</i>, confers resistance to isoniazid and ethionamide in <i>Mycobacterium smegmatis</i>, <i>M. bovis</i> BCG and <i> M. tuberculosis</i>Michelle H. Larsen, William R. Jacobs, Catherine Vilchèze et al.|Molecular Microbiology|2002Cited by 202